Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

Reducing P38MAPK Levels Delays Aging Of Multiple Tissues In Lab Mice
In the new issue of the Developmental Cell journal, a team of scientists at Singapore"s Agency for Science, Technology and Research (A*STAR) and the University of North Carolina School of Medicine at Chapel Hill, report research findings about the molecular mechanisms behind the aging process, which has up till now been poorly understood, that offer the possibility that a novel, pharmacological approach could be developed to combat age-related disorders.
generic viagra online
Merck Issues Statement On WHO Study Showing First Evidence That Elimination Of River Blindness Is Feasible In Africa
Merck & Co., Inc. issued the following statement in response to study results published today by the World Health Organization offering the first evidence that elimination of the tropical disease river blindness (onchocerciasis) in Africa is feasible with treatment with ivermectin (registered trademark Mectizan®). As the discoverer and manufacturer of Mectizan, Merck decided in 1987 to donate the drug to all who need it for as long as necessary until river blindness is eliminated as a public health problem. The Merck Mectizan Donation Program is one of the longest-running disease-specific drug donation and public/private partnership programs in history.
News of the day
'Virtual World' Training For Public Health Emergencies Evaluated By UIC
Researchers at the University of Illinois at Chicago School of Public Health are conducting a study to determine if collaborative virtual environments improve public health preparedness and response planning.
Sexual Health

Government Responds To Archer Inquiry

The Government today responded to the independent inquiry into contaminated blood supplies in the 1970s and 1980s. In a Written Ministerial Statement, Public Health Minister Dawn Primarolo set out the Government"s response to the Archer Inquiry into individuals infected by HIV and hepatitis C through infected NHS blood and blood products. The response includes: - there will be a significant increase in annual payments to ÷£12,800 for individuals infected with HIV, in addition to the ÷£45 million already given out in lump sums and discretionary payments; - further support for the Haemophilia Society of ÷£100,000 per year for the next five years; and - a commitment to review the financial relief for individuals affected by hepatitis C in five years. Tough measures are already in place to prevent similar events happening in the future. To ensure all patients with bleeding disorders who may have been infected have been identified, a look back exercise will be undertaken. Minister for Public Health, Dawn Primarolo said: "I would like to offer my deepest sympathy to all those who suffered in this tragic episode. Sadly, it was not possible to effectively test for these viruses in the 1970s and early 80s and we deeply regret that these events occurred following NHS treatment. "Steps to safeguard blood products against HIV and hepatitis C have been in place since 1985. Every reasonable step to minimise risks from blood transfusion has been taken and robust screening measures are in place to protect patients. "In addition to the ÷£150 million already given out in lump sums and discretionary payments to those infected with HIV and hepatitis C, financial help for those infected with HIV will rise to ÷£12,800 per year." The full response to Lord Archer"s report has been placed in the Library of the House. In keeping with the Government"s commitment to make information available that relates to this period, the remaining 468 relevant documents have been placed on the Department of Health website. The Macfarlane Trust and Eileen Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009